covid-19 boosters

Explore "covid-19 boosters" with insightful episodes like "The Latest COVID Booster Is Here. Should You Get It?", "The ‘Tripledemic’ Explained", "Episode 167 - Boosters, Baby!", "When Should I Get My Omicron Booster Shot?" and "When To Consider Another COVID-19 Booster" from podcasts like ""Short Wave", "The Daily", "The House of Pod: A Medical Podcast", "Short Wave" and "Short Wave"" and more!

Episodes (8)

The Latest COVID Booster Is Here. Should You Get It?

This week, the Food and Drug Administration approved new COVID vaccines this week. It comes at a time when COVID cases, hospitalizations and deaths are on the rise. It's also the first time that the federal government is not paying for the vaccines. Given this confluence of events, we huddled with our colleagues, intrepid health correspondents Maria Godoy and Rob Stein. They gave us the lowdown on the CDC's recommendations for who should get it, how protective the booster is, how to access it regardless of your insurance status—and even how time this booster with other vaccines that may be on your radar.

Check out Rob and Maria's full COVID booster Q&A here.

Have health question? Email us at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Short Wave

en-usSeptember 15, 2023

vaccine effectiveness

The ‘Tripledemic’ Explained

This winter, three major respiratory viruses — respiratory syncytial virus or R.S.V., the flu and the coronavirus — are poised to collide in the United States in what some health officials are calling a “tripledemic.”

What does this collision have to do with our response to the coronavirus pandemic, and why are children so far the worst affected?

Guest: Apoorva Mandavilli, a science and global health reporter for The New York Times.

Background reading:

Most cases of Covid, flu and R.S.V. are likely to be mild, but together they may sicken millions of Americans and swamp hospitals, public health experts warned.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

enNovember 22, 2022

pediatric hospitalizations

rsv surge

Episode 167 - Boosters, Baby!

Kaveh takes a deep dive on the first bivalent COVID booster to learn what "imprinting" is, if you can take meds to help with the symptoms of the vaccine, and answer a bunch more questions we all have about the new booster! With Edward Nirenberg, Dr. Neurofourier and Dr. Jeff McLeroy. Send your questions and comments to hopquestions@gmail.com.

Hosted on Acast. See acast.com/privacy for more information.

The House of Pod: A Medical Podcast

enSeptember 21, 2022

vaccine communication

When Should I Get My Omicron Booster Shot?

Updated COVID boosters are now available that target the Omicron subvariant and many Americans 12 and older are eligible for the shot. Host Emily Kwong and health correspondent Allison Aubrey talk about who should get it, when, and whether there's a case to be made for skipping this booster.

You can read more about Allison's reporting at "Omicron boosters: Do I need one, and if so, when?"

Follow Short Wave on Twitter @NPRShortWave. You can also email us at ShortWave@NPR.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Short Wave

en-usSeptember 13, 2022

immunity

flu shot

vulnerable populations

covid-19 boosters

omicron variants

When To Consider Another COVID-19 Booster

This week, U.S. Food and Drug Administration vaccine advisors will meet to discuss long-term COVID vaccine strategy. This follows the recent FDA authorization and CDC recommendation of a second booster available for people 50 and older and some immunocompromised people. Going forward, will the strategy change from counting boosters to making a COVID vaccine a seasonal shot? Allison Aubrey talks to Emily Kwong about the latest on boosters, what's known about the vaccination timeline for younger children, and what some experts are saying about the BA.2 variant.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

en-usApril 05, 2022

COVID-19 boosters are here

The United States is on the verge of dramatically expanding the availability of COVID-19 vaccine boosters to shore up people's immune systems. As NPR health correspondent Rob Stein reports, the Food and Drug Administration is poised to authorize the boosters of the Moderna and Johnson & Johnson vaccines. Still, many experts argue boosters aren't needed because the vaccines are working well and it would be unethical to give people in the U.S. extra shots when most of the world is still waiting for their first.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Short Wave

en-usOctober 19, 2021

expert recommendations

“Third shot’s the charm.”

President Biden grapples with criticism from Republicans like Donald Trump, journalists, pundits, and fellow Democrats over the withdrawal of American forces from Afghanistan. Then, Surgeon General Vivek Murthy talks with Jon Favreau about the Administration’s announcement that Americans will be offered Covid-19 booster shots starting in late September.

For a closed-captioned version of this episode, please visit crooked.com/podsaveamerica.

For a transcript of this episode, please email transcripts@crooked.com and include the name of the podcast.

Pod Save America

enAugust 19, 2021

media bias

afghanistan withdrawal

biden approval

covid-19 boosters

immigration and refugees

Do We Need a Third Covid Shot?

The rise of the Delta variant has prompted a thorny question: Do we need a booster dose of the vaccine for Covid-19? Vaccine makers think so, but regulators are yet to be convinced.

Principles are also at stake: Should richer countries be talking about administering extra doses when so many people around the world are yet to receive even a single shot?

Guest: Rebecca Robbins, a business reporter covering Covid-19 vaccines for The New York Times.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter.

Background reading:

Although studies of a third dose are underway, experts agree that the vaccines are still working well. Here’s what to know about the potential booster dose.
U.S. officials said that the decision to go ahead with a booster shot would depend partly on how many infections cause serious disease or hospitalization in vaccinated people.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

enJuly 19, 2021